The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of PD-L1 and KRAS status on the efficacy of nintedanib (NIN) + docetaxel (DOC) following treatment with first-line immune checkpoint inhibitor (ICI) + chemotherapy in patients with adenocarcinoma NSCLC: Analysis of cohort C of the non-interventional VARGADO trial.
 
Christian Grohé
Honoraria - AstraZeneca; Boehringer Ingelheim; Lilly; MSD Oncology; Novartis; Roche; Takeda
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; MSD Oncology
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; Roche
 
Thomas Wehler
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; Merck; MSD; Pfizer; Roche; Sanofi
Consulting or Advisory Role - Pfizer
Research Funding - AstraZeneca; Boehringer Ingelheim
Travel, Accommodations, Expenses - Pfizer
 
Sven Henschke
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Janssen-Cilag; Johnson & Johnson; Roche
Speakers' Bureau - Bristol-Myers Squibb; Roche
Research Funding - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Roche; Sanofi
Travel, Accommodations, Expenses - Janssen-Cilag; Johnson & Johnson; Movember Foundation
 
Stefan Hammerschmidt
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Roche
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Roche
 
Christoph Aulmann
No Relationships to Disclose
 
Stefan Krüger
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Pfizer; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Pfizer
Research Funding - Boehringer Ingelheim; MSD; Roche
Travel, Accommodations, Expenses - Boehringer Ingelheim
 
Ina Dittrich
Consulting or Advisory Role - AstraZeneca; Boehringer Pharma GmbH; Bristol-Myers Squibb; Pfizer
 
Wolfgang Schuette
Consulting or Advisory Role - Boehringer Ingelheim
Travel, Accommodations, Expenses - Boehringer Ingelheim; Roche
 
Eyck von der Heyde
No Relationships to Disclose
 
Sven Hanson
Employment - Boehringer Ingelheim
 
Joerg Bajorat
Employment - Boehringer Ingelheim
 
Rolf Kaiser
Employment - Boehringer Ingelheim